Clinic features and prognostic analysis for T1 esophagus cancer
10.3760/cma.j.issn.0253-3766.2018.04.006
- VernacularTitle: T1期浸润性原发性食管癌的临床病理特征及预后
- Author:
Zhe YU
1
;
Xiaomin LI
2
;
Mei HUAI
1
;
Guijie LU
3
;
Chong WANG
4
;
Quanyu WANG
5
;
Qingyi LIU
6
Author Information
1. Department of Cardio-Thoracic Surgery, the General Hospital of Huabei Petroleum Administration, Renqiu 062550, China
2. Department of Pathology, the General Hospital of Huabei Petroleum Administration, Renqiu 062550, China
3. Department of Clinical Laboratory, the General Hospital of Huabei Petroleum Administration, Renqiu 062550, China
4. Department of Imaging, the General Hospital of Huabei Petroleum Administration, Renqiu 062550, China
5. Department of Interventional Radiology, the General Hospital of Huabei Petroleum Administration, Renqiu 062550, China
6. Department of Cardio-Thoracic Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050000, China
- Publication Type:Clinical Trail
- Keywords:
Esophageal neoplasms;
Pathology, clinical;
Metastasis of lymph node;
Prognosis;
Chemoradiotherapy, adjuvant
- From:
Chinese Journal of Oncology
2018;40(4):268-273
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate relationship between the clinicopathological features and prognosis of T1 esophageal carcinoma.
Methods:Data from 212 T1 primary esophageal cancer patients, who underwent radical surgery in The Fourth Hospital of Hebei Medical University from Jan 2001 to Dec 2009 were enrolled. There were 148 males and 64 females. There were 91 patients with stage pT1a and 121 patients with stage pT1b.
Results:The survival of the 212 patients was 27~108 months, and the median survival was 80.8 months. The 1, 3, and 5 year survival rates of patients with stage T1a were 100%, 97.8% and 94.5%, respectively, and the median survival was 86.8 months. The 1, 3, and 5 year survival rates of patients with stage T1b were 100%, 95.9% and 74.4%, respectively, and the median survival was 76.2 months. The rate of lymph node metastasis in 121 patients with stage T1b was 26.4% (32/121). The lymph node metastasis rates in patients with stage sm1, sm2 and sm3 were 11.6% (3/26), 15.0% (6/40) and 41.8% (23/55), respectively. There was no significant difference in lymph node metastasis between stage sm1 patients and stage sm2 patients (P=0.973). Lymph node metastasis rates in patients with stage sm3 were higher than those in stage sm1 and sm2 (P<0.05).
Conclusion:Radical resection of esophageal carcinoma with peripheral lymph node dissection is recommended for patients with T1b esophageal carcinoma.
